Australia markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
35.58+0.31 (+0.88%)
At close: 04:00PM EDT
35.70 +0.12 (+0.34%)
After hours: 07:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 70.46B
Enterprise value 86.81B
Trailing P/E 13.19
Forward P/E 9.63
PEG ratio (5-yr expected) 1.95
Price/sales (ttm)2.01
Price/book (mrq)5.57
Enterprise value/revenue 2.96
Enterprise value/EBITDA 10.09

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3-18.67%
S&P500 52-week change 3-10.33%
52-week high 346.97
52-week low 328.47
50-day moving average 334.97
200-day moving average 335.30

Share statistics

Avg vol (3-month) 33.66M
Avg vol (10-day) 32.99M
Shares outstanding 52.05B
Implied shares outstanding 6N/A
Float 81.95B
% held by insiders 10.03%
% held by institutions 113.97%
Shares short (14 Mar 2023) 43.84M
Short ratio (14 Mar 2023) 41.11
Short % of float (14 Mar 2023) 4N/A
Short % of shares outstanding (14 Mar 2023) 40.19%
Shares short (prior month 14 Feb 2023) 43.74M

Dividends & splits

Forward annual dividend rate 41.48
Forward annual dividend yield 44.20%
Trailing annual dividend rate 30.61
Trailing annual dividend yield 31.74%
5-year average dividend yield 45.29
Payout ratio 469.00%
Dividend date 312 Apr 2023
Ex-dividend date 422 Feb 2023
Last split factor 21226:1000
Last split date 321 July 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 51.00%
Operating margin (ttm)24.97%

Management effectiveness

Return on assets (ttm)6.57%
Return on equity (ttm)31.31%

Income statement

Revenue (ttm)29.32B
Revenue per share (ttm)14.57
Quarterly revenue growth (yoy)4.20%
Gross profit (ttm)19.92B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)2.71
Quarterly earnings growth (yoy)167.20%

Balance sheet

Total cash (mrq)8.73B
Total cash per share (mrq)4.32
Total debt (mrq)20.99B
Total debt/equity (mrq)207.87
Current ratio (mrq)0.91
Book value per share (mrq)5.25

Cash flow statement

Operating cash flow (ttm)7.4B
Levered free cash flow (ttm)4.95B